Gentamicin Ototoxicity

3

Review clinical trials related to Gentamicin Ototoxicity. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Long Term Outcomes After Vestibular Implantation

Although cochlear implants can restore hearing to individuals who have lost cochlear hair cell function, there is no widely available, adequately effective treatment for individuals suffering chronic imbalance, postural instability and unsteady vision due to bilateral vestibular hypofunction. Prior research focused on ototoxic cases has demonstrated that electrical stimulation of the vestibular nerve via a chronically implanted multichannel vestibular implant can partially restore vestibular reflexes that normally maintain steady posture and vision; improve performance on objective measures of postural stability and gait; and improve patient-reported disability and health-related quality of life. This single-arm open-label study extends that research to evaluate outcomes for up to 8 individuals with non-ototoxic bilateral vestibular hypofunction, yielding a total of fifteen adults (age 22-90 years at time of enrollment) divided as equally as possible between ototoxic and non-ototoxic cases.

Participants needed: 32
Trial details
Age: 22-90Biological sex: AllType: InterventionalSponsor: Johns Hopkins UniversityUpdated: Mar 9, 2026Locations: 1
Eligibility criteria

Adults older than 22 years old who [+2]

Status: Recruiting

Vestibular Implantation in Older Adults

Although cochlear implants can restore hearing to individuals who have lost cochlear hair cell function, there is no widely available, adequately effective treatment for individuals suffering chronic imbalance, postural instability and unsteady vision due to bilateral vestibular hypofunction. Prior research has demonstrated that electrical stimulation of the vestibular nerve via a chronically implanted multichannel vestibular implant can partially restore vestibular reflexes that normally maintain steady posture and vision; improve performance on objective measures of postural stability and gait; and improve patient-reported disability and health-related quality of life. This single-arm open-label study extends that research to evaluate outcomes for up to fifteen older adults (age 65-90 years at time of enrollment) with ototoxic or non-ototoxic bilateral vestibular hypofunction.

Participants needed: 15
Trial details
Age: 65-90Biological sex: AllType: InterventionalSponsor: Johns Hopkins UniversityUpdated: Jan 12, 2026Locations: 1
Eligibility criteria

Adults age 65-90 years diagnosed with ototoxic, idiopathic or non-ototoxic/non-c... [+9]

Inability to understand the procedures and the potential risks involved as deter... [+19]

Status: Recruiting

Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction

Although cochlear implants can restore hearing to individuals who have lost cochlear hair cell function, there is no widely available, adequately effective treatment for individuals suffering chronic imbalance, postural instability and unsteady vision due to bilateral vestibular hypofunction. Prior research focused on ototoxic cases has demonstrated that electrical stimulation of the vestibular nerve via a chronically implanted multichannel vestibular implant can partially restore vestibular reflexes that normally maintain steady posture and vision; improve performance on objective measures of postural stability and gait; and improve patient-reported disability and health-related quality of life. This single-arm open-label study extends that research to evaluate outcomes for up to 8 individuals with non-ototoxic bilateral vestibular hypofunction, yielding a total of fifteen adults (age 22-90 years at time of enrollment) divided as equally as possible between ototoxic and non-ototoxic cases.

Participants needed: 8
Trial details
Age: 22-90Biological sex: AllType: InterventionalSponsor: Johns Hopkins UniversityUpdated: Jan 12, 2026Locations: 1
Eligibility criteria

Adults age 22-90 years diagnosed with ototoxic, idiopathic or non-ototoxic/non-c... [+9]

Inability to understand the procedures and the potential risks involved as deter... [+19]